Capital Flow Monitor · Sponsors · CIK 1882991
Alphina Therapeutics, Inc.
55 Church Street, New Haven, CT, 06510 · (650) 438-8738
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$10.0M
Sold
$154K
% sold
1.5%
Investors
3
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-03-16 | D ·current | 506(b) | $10.0M | $154K | 1.5% | 3 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Nicholas J Galli — Executive Officer / Director, New Haven, CT
-
Ranjit Bindra — Director, New Haven, CT
1 other raise
- CapeHaven Holding Company, LLC $1.4M of $5.0M · 28.9%
-
Kevin Rakin — Director, New Haven, CT
1 other raise
- Convexity Scientific Inc. $10.0M of $13.0M · 77.0%
- Colleen Cuffaro — Director, Westport, CT
- Barbara Fox — Executive Officer / Director, New Haven, CT
-
Matthew Cohen — Director, Bala Cynwyd, PA
6 other raises
- Declaration Partners Real Estate Fund III-A LP $0 of —
- Declaration Partners Real Estate Fund III LP $0 of —
- APCP Mezz Holdco, LLC $3.1M of $3.7M · 82.7%
- Vida Ventures IV, L.P. $0 of $500.0M · 0.0%
- Provable Holdings US, Inc. $7.5M of $13.5M · 55.6%
- APCP TX Holdco, LLC $4.5M of $4.5M · 100.0%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.